12401 West Olympic Boulevard
United States - Map
VCA Inc. operates as an animal healthcare company in the United States and Canada. It operates through Animal Hospital and Laboratory segments. The Animal Hospital segment offers general medical and surgical services for companion animals, as well as specialized treatments comprising advanced diagnostic services, internal medicine, oncology, neurology, endocrinology, ophthalmology, dermatology, and cardiology; and sells related retail and pharmaceutical products. It also provides specialty pet products, including pet food, vitamins, therapeutic shampoos and conditioners, flea collars and sprays, and other accessory products; and additional services, such as grooming, bathing, and boarding services. In addition, it performs various pet wellness programs, such as health examinations, diagnostic testing, routine vaccinations, spaying, neutering, and dental care. As of June 30, 2015, it operated or managed 657 animal hospitals. The Laboratory segment offers testing and consulting services in the areas of in the detection, diagnosis, evaluation, monitoring, treatment, and prevention of diseases, as well as in other conditions affecting animals. This segment serves animal hospitals, animal practices, universities, and other government organizations. As of June 30, 2015, its laboratory network consisted of 59 laboratories. The company also sells digital radiography and ultrasound imaging equipment, related computer hardware, software, and ancillary services to the veterinary market; provides online and printed communications, professional education, and marketing solutions to the veterinary community; and offers an e-commerce platform for independent animal hospitals, as well as consulting and mobile imaging services. The company was formerly known as VCA Antech, Inc. and changed its name to VCA Inc. in June 2014. VCA Inc. was founded in 1986 and is headquartered in Los Angeles, California.
|VCA Inc.’s ISS Governance QuickScore as of Aug 1, 2015 is 3. The pillar scores are Audit: 1; Board: 7; Shareholder Rights: 5; Compensation: 2.|
|Brought to you by Institutional Shareholder Services (ISS)|
|Mr. Robert L. Antin ,
Co-Founder, Chairman, Chief Exec. Officer and Pres
|Mr. Arthur J. Antin ,
Co-Founder, Chief Operating Officer and Sr. VP
|Mr. Neil Tauber ,
Co-Founder and Sr. VP of Devel.
|Mr. Tomas W. Fuller ,
Chief Financial Officer, Principal Accounting Officer, VP and Sec.
|Mr. Josh Drake ,
Pres of Antech Diagnostics
|Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|